Deep brain stimulation for control of refractory hypertension

Area of Science:

• Neurology
• Cardiovascular Medicine
• Neurosurgery

Background:

• Severe, drug-resistant hypertension poses significant health risks.
• Established non-pharmacological treatments like renal denervation and baroreflex activation therapy may fail.
• Deep brain stimulation (DBS) is an emerging therapeutic option for refractory hypertension.

Purpose of the Study:

• To evaluate the efficacy of DBS targeting the ventrolateral periaqueductal gray (vlPAG) for severe hypertension.
• To explore the mechanisms by which DBS influences blood pressure regulation.
• To discuss advancements and future directions in DBS for hypertension.

Main Methods:

• Review of case studies demonstrating long-term blood pressure reduction with DBS.
• Analysis of the proposed mechanism involving modulation of autonomic control centers.
• Discussion of recent research on DBS targets and physiological effects.

Main Results:

• Case studies indicate sustained reductions in blood pressure following DBS of the vlPAG.
• DBS is hypothesized to reduce sympathetic outflow, thereby lowering blood pressure.
• The potential for DBS to restore physiological blood pressure patterns, like diurnal variation, is under investigation.

Conclusions:

• DBS of the vlPAG is a promising strategy for managing severe, treatment-resistant hypertension.
• Further research is needed to confirm the robustness of the vlPAG as a sole target and to optimize DBS parameters.
• DBS may offer a novel approach to restoring normal blood pressure dynamics.